David B. Roberts - Dec 2, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: President and Director, Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol: LMAT
Transactions as of: Dec 2, 2022
Transactions value $: -$4,811
Form type: 4
Date filed: 12/6/2022, 05:19 PM
Previous filing: Dec 5, 2022
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$0	+4	+0.03%	$0.00	14.8K	Dec 2, 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	-$4.81K	-102	-0.69%	$47.17	14.6K	Dec 2, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-4	-16.96%	$0.00	19.6	Dec 2, 2022	Common Stock	4	$0.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/2/2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/2/2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.